Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Letters

Volume 30—2024

Volume 30, Number 11—November 2024

Cover of issue Volume 30, Number 11—November 2024

Estimating Underdetection of Foodborne Disease Outbreaks [PDF - 238 KB - 1 page]
C. W. Hedberg et al.
EID Hedberg CW, Firestone MJ, Kim TN, Edmundson AR, Bender JB. Estimating Underdetection of Foodborne Disease Outbreaks. Emerg Infect Dis. 2024;30(11):2451. https://doi.org/10.3201/eid3011.240198
AMA Hedberg CW, Firestone MJ, Kim TN, et al. Estimating Underdetection of Foodborne Disease Outbreaks. Emerging Infectious Diseases. 2024;30(11):2451. doi:10.3201/eid3011.240198.
APA Hedberg, C. W., Firestone, M. J., Kim, T. N., Edmundson, A. R., & Bender, J. B. (2024). Estimating Underdetection of Foodborne Disease Outbreaks. Emerging Infectious Diseases, 30(11), 2451. https://doi.org/10.3201/eid3011.240198.

Estimating Underdetection of Foodborne Disease Outbreaks (Response) [PDF - 286 KB - 1 page]
L. Ford et al.
EID Ford L, Self JL, Wong KK, Hoekstra RM, Tauxe RV, Rose E, et al. Estimating Underdetection of Foodborne Disease Outbreaks (Response). Emerg Infect Dis. 2024;30(11):2452. https://doi.org/10.3201/eid3011.241351
AMA Ford L, Self JL, Wong KK, et al. Estimating Underdetection of Foodborne Disease Outbreaks (Response). Emerging Infectious Diseases. 2024;30(11):2452. doi:10.3201/eid3011.241351.
APA Ford, L., Self, J. L., Wong, K. K., Hoekstra, R. M., Tauxe, R. V., Rose, E....Bruce, B. B. (2024). Estimating Underdetection of Foodborne Disease Outbreaks (Response). Emerging Infectious Diseases, 30(11), 2452. https://doi.org/10.3201/eid3011.241351.

Volume 30, Number 8—August 2024

Cover of issue Volume 30, Number 8—August 2024

Transmission and Surveillance of Rat Hepatitis E Virus in Swine [PDF - 236 KB - 1 page]
M. Bezerra et al.
EID Bezerra M, Oliveira da Paz M, de Oliveira-Filho E, de Souza Reis C. Transmission and Surveillance of Rat Hepatitis E Virus in Swine. Emerg Infect Dis. 2024;30(8):1739. https://doi.org/10.3201/eid3008.240484
AMA Bezerra M, Oliveira da Paz M, de Oliveira-Filho E, et al. Transmission and Surveillance of Rat Hepatitis E Virus in Swine. Emerging Infectious Diseases. 2024;30(8):1739. doi:10.3201/eid3008.240484.
APA Bezerra, M., Oliveira da Paz, M., de Oliveira-Filho, E., & de Souza Reis, C. (2024). Transmission and Surveillance of Rat Hepatitis E Virus in Swine. Emerging Infectious Diseases, 30(8), 1739. https://doi.org/10.3201/eid3008.240484.

Volume 30, Number 6—June 2024

Cover of issue Volume 30, Number 6—June 2024

Nontuberculous Mycobacteria and Laboratory Surveillance, Virginia, USA [PDF - 230 KB - 1 page]
I. See et al.
EID See I, Jackson KA, Byram R, Toney N, Grigg C, Magill SS. Nontuberculous Mycobacteria and Laboratory Surveillance, Virginia, USA. Emerg Infect Dis. 2024;30(6):1302. https://doi.org/10.3201/eid3006.240431
AMA See I, Jackson KA, Byram R, et al. Nontuberculous Mycobacteria and Laboratory Surveillance, Virginia, USA. Emerging Infectious Diseases. 2024;30(6):1302. doi:10.3201/eid3006.240431.
APA See, I., Jackson, K. A., Byram, R., Toney, N., Grigg, C., & Magill, S. S. (2024). Nontuberculous Mycobacteria and Laboratory Surveillance, Virginia, USA. Emerging Infectious Diseases, 30(6), 1302. https://doi.org/10.3201/eid3006.240431.

Volume 30, Number 2—February 2024

Cover of issue Volume 30, Number 2—February 2024

No Evidence for Clade I Monkeypox Virus Circulation, Belgium [PDF - 230 KB - 1 page]
L. Liesenborghs et al.
EID Liesenborghs L, Coppens J, Van Dijck C, Brosius I, De Baetselier I, Vercauteren K, et al. No Evidence for Clade I Monkeypox Virus Circulation, Belgium. Emerg Infect Dis. 2024;30(2):402. https://doi.org/10.3201/eid3002.231746
AMA Liesenborghs L, Coppens J, Van Dijck C, et al. No Evidence for Clade I Monkeypox Virus Circulation, Belgium. Emerging Infectious Diseases. 2024;30(2):402. doi:10.3201/eid3002.231746.
APA Liesenborghs, L., Coppens, J., Van Dijck, C., Brosius, I., De Baetselier, I., Vercauteren, K....Van Esbroeck, M. (2024). No Evidence for Clade I Monkeypox Virus Circulation, Belgium. Emerging Infectious Diseases, 30(2), 402. https://doi.org/10.3201/eid3002.231746.

Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan [PDF - 236 KB - 1 page]
K. Iwata
EID Iwata K. Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan. Emerg Infect Dis. 2024;30(2):403. https://doi.org/10.3201/eid3002.230827
AMA Iwata K. Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan. Emerging Infectious Diseases. 2024;30(2):403. doi:10.3201/eid3002.230827.
APA Iwata, K. (2024). Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan. Emerging Infectious Diseases, 30(2), 403. https://doi.org/10.3201/eid3002.230827.

Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan (Response) [PDF - 474 KB - 2 pages]
T. Aita et al.
EID Aita T, Sando E, Katoh S, Hamaguchi S, Fujita H, Kurita N. Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan (Response). Emerg Infect Dis. 2024;30(2):403-404. https://doi.org/10.3201/eid3002.231465
AMA Aita T, Sando E, Katoh S, et al. Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan (Response). Emerging Infectious Diseases. 2024;30(2):403-404. doi:10.3201/eid3002.231465.
APA Aita, T., Sando, E., Katoh, S., Hamaguchi, S., Fujita, H., & Kurita, N. (2024). Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan (Response). Emerging Infectious Diseases, 30(2), 403-404. https://doi.org/10.3201/eid3002.231465.

Volume 30, Number 1—January 2024

Cover of issue Volume 30, Number 1—January 2024

Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany [PDF - 229 KB - 1 page]
J. de Bellocq et al.
EID de Bellocq J, Baird S, Fornůsková A. Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany. Emerg Infect Dis. 2024;30(1):205. https://doi.org/10.3201/eid3001.230334
AMA de Bellocq J, Baird S, Fornůsková A. Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany. Emerging Infectious Diseases. 2024;30(1):205. doi:10.3201/eid3001.230334.
APA de Bellocq, J., Baird, S., & Fornůsková, A. (2024). Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany. Emerging Infectious Diseases, 30(1), 205. https://doi.org/10.3201/eid3001.230334.

Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany (Response) [PDF - 236 KB - 2 pages]
C. Mehl et al.
EID Mehl C, Wylezich C, Geiger C, Schauerte N, Mätz-Rensing K, Nesseler A, et al. Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany (Response). Emerg Infect Dis. 2024;30(1):205-206. https://doi.org/10.3201/eid3001.231521
AMA Mehl C, Wylezich C, Geiger C, et al. Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany (Response). Emerging Infectious Diseases. 2024;30(1):205-206. doi:10.3201/eid3001.231521.
APA Mehl, C., Wylezich, C., Geiger, C., Schauerte, N., Mätz-Rensing, K., Nesseler, A....Ulrich, R. G. (2024). Use of Zoo Mice in Study of Lymphocytic Choriomeningitis Mammarenavirus, Germany (Response). Emerging Infectious Diseases, 30(1), 205-206. https://doi.org/10.3201/eid3001.231521.

SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan [PDF - 276 KB - 2 pages]
H. Cheng et al.
EID Cheng H, Akhmetzhanov AR, Dushoff J. SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan. Emerg Infect Dis. 2024;30(1):206-207. https://doi.org/10.3201/eid3001.230208
AMA Cheng H, Akhmetzhanov AR, Dushoff J. SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan. Emerging Infectious Diseases. 2024;30(1):206-207. doi:10.3201/eid3001.230208.
APA Cheng, H., Akhmetzhanov, A. R., & Dushoff, J. (2024). SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan. Emerging Infectious Diseases, 30(1), 206-207. https://doi.org/10.3201/eid3001.230208.

SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan (Response) [PDF - 252 KB - 1 page]
T. Ogata and H. Tanaka
EID Ogata T, Tanaka H. SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan (Response). Emerg Infect Dis. 2024;30(1):207. https://doi.org/10.3201/eid3001.231487
AMA Ogata T, Tanaka H. SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan (Response). Emerging Infectious Diseases. 2024;30(1):207. doi:10.3201/eid3001.231487.
APA Ogata, T., & Tanaka, H. (2024). SARS-CoV-2 Incubation Period during Omicron BA.5–Dominant Period, Japan (Response). Emerging Infectious Diseases, 30(1), 207. https://doi.org/10.3201/eid3001.231487.
Page created: November 07, 2023
Page updated: October 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
edit_01 ScholarOne Submission Portal
Issue Select
GO
GO

Spotlight Topics

 

 

Get Email Updates

To receive email updates about this page, enter your email address:

file_external